Tyco Medical Products Sales To Hit $4.5 Bil. With U.S. Surgical Acquisition
This article was originally published in The Gray Sheet
Executive SummaryTyco International's medical device business will reach $4.5 bil. following the $3.3 bil. purchase of U.S. Surgical Corp. The total includes USSC's estimated $1.4 bil. in 1998 sales and revenue from Tyco's previous acquisitions of Sherwood-Davis & Geck and Kendall, making up a substantial portion of the conglomerate's overall $13 bil. in annual volume.
You may also be interested in...
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Landmark studies of newer techniques have led the American Urological Association to update its guidelines.